Advisory Committees

Recipient Representatives Advisory Committee

"It is recommended that, in addition to the customary committees of a corporate board of directors, the following standing committees be created to facilitate the work of the national blood service:

A Recipient Representatives Advisory Committee, consisting of representatives of community and consumer organizations. This committee should ensure that special interests are brought to the attention of the board and that there is adequate communication between the national blood service and any pertinent external organizations, including community and national organizations for recipients, public health organizations, and national and international health and blood-banking organizations. It should also advise the board about the development of educational material for donors and consumers."

Mr. Justice Horace Krever, Commission of Inquiry on the Blood System in Canada, Final report, Volume 3, p. 1055.

  • Establish effective lines of communication between Héma-Québec and the various groups representing recipients of blood components, derivatives and substitutes, and ensure that their particular interests are brought to the attention of the Board of Directors.
  • Ensure that recipients of blood components, derivatives and substitutes and other interested parties are promptly informed of any development and/or change in the supply system that might affect them.
  • Enable recipients of blood components, derivatives and substitutes and other interested parties to present their positions on any subject that concerns them.
  • Take part in preparing for Héma-Québec Board of Directors public meetings.
  • The committee is composed of 10 external voting members.
  • The committee shall meet at last once per year.
  • Members shall sit for a renewable term of three or five years. They shall remain in their position until they are replaced or their mandate is renewed.
  • The external members shall all be recipients of labile or stable blood products or individuals associated with organizations that represent the interests of these recipients from among the following organizations:
Organizations
Canadian Hemophilia Society - Québec chapter
Association des grands brûlés
Québec Society of Thalassemia
LEUCAN
The Canadian Sickle Cell Society
Québec Sickle Cell Association
COCQ-sida
Association générale de l'insuffisance rénale
Multiple Sclerosis Society of Canada
Conseil pour la protection des malades (CPM)
  • Each of the organizations listed above will be invited to submit applications to the Board of Directors for two representatives. These applications must be accompanied by a curriculum vitæ and/or a letter from the individual indicating their interest in sitting on the committee.
  • The Board of Directors appoints the external members from among the candidates recommended.
  • A member of the committee of recipients’ associations for the Canadian Blood Services (CBS) may be invited to attend as an observer. This member shall serve for a term of three years and shall remain in that position until replaced or re-appointed. In the event that this member ceases to be a member of the CBS recipients’ committee, their mandate shall end immediately and the committee in question shall appoint another representative.
  • The chair shall be held by an external member and voted by the members. The chair shall serve a term of two years and shall remain in that position until replaced or re-elected.
  • At least two members of Héma-Québec's Board of Directors, one of them the member selected from among those proposed by the recipients' associations, shall attend as observers, but all members of Héma-Québec's Board shall be invited to attend meetings as observers, should they so wish.
  • A member of the Association of Blood Donation Volunteers shall also be invited to attend as an observer.

Selection of the recipients' representatives to sit on the Safety Committee, the Scientific and Medical Advisory Committee and the Research Ethics Committee.

The Recipient Representatives Advisory Committee will select the recipients’ representatives to sit on the Safety Advisory Committee, the Scientific and Medical Advisory Committee, and the Research Ethics Committee.

Scientific and Medical Advisory Committee

"It is recommended that, in addition to the customary committees of a corporate board of directors, the following standing committees be created to facilitate the work of the national blood service:

A scientific and medical advisory committee, to keep abreast of the frequent and rapid technical and scientific developments that affect the blood supply system. This committee should ensure that the board of directors always has current information about scientific developments. It should also advise the board about the expenditure of the research funds for the blood supply system and should monitor technical developments affecting the blood supply system, including alternatives to blood components and blood products, and methods of improving the safety and efficacy of blood components and blood products."

Mr. Justice Horace Krever, Commission of Inquiry on the Blood System in Canada, Final Report, Volume 3, p. 1055.

  • Advise the Board of Directors on scientific and medical developments that might have an impact on the supply of blood components, derivatives and substitutes, particularly technological developments, therapeutic effectiveness and replacement products.
  • Advise the Board of Directors on the scientific pertinence of the research and development programs and the specialized services offered by Héma-Québec as well as their costs.
  • At regular intervals, assess the state of progress of Héma-Québec's research and development programs and specialized services and advise the Board of Directors thereon.
  • Advise the Board of Directors on Héma-Québec's policies and procedures for research and development and specialized services.
  • The committee consists of 12 external voting members.
    • The committee shall meet at least once per year.
    • The Board of Directors shall appoint the external members after studying their curriculum vitæ.
  • The chair shall be held by an external member and voted in by the members. The chair shall serve a term of two (2) years and shall remain in that position until replaced or re-elected.
  • Conflicts of interest (organization and intellectual property) must be avoided when choosing external members. In addition, external members must sign a confidentiality agreement.
  • Members sit for a renewable term of five (5) years. They shall remain in their position until they are replaced or their mandate is renewed.
  • At least two (2) members of Héma-Québec’s Board of Directors shall sit as observers. However, all members of Héma-Québec’s Board of Directors shall be invited to attend meetings as observers, should they so wish.
  • Some Héma-Québec employees are invited to attend meetings and to perform clerical duties for the committee.
  • A member of the Liaison Committee will be appointed by that committee to sit on the Scientific and Medical Advisory Committee.
  • At the request of Héma-Québec, a representative of the Canadian Blood Services (CBS) shall be appointed by the CBS. This member shall serve for a term of five years and shall remain in that position until replaced or re-appointed. In the event that this member terminates their employment with the CBS, their mandate shall end immediately and the CBS shall appoint another representative.

The member selection process must take into account the following fields:

Fields
Transfusion medicine
Molecular biology
Biotechnology
Plasma derivatives
Blood component and tissue manufacturing
Hematopoiesis
Immunology
Industrial research
Diagnostic technologies

Safety Advisory Committee

“It is recommended that, in addition to the customary committees of a corporate board of directors, the following standing committee be created to facilitate the work of the national blood service:

A safety committee, consisting of persons from the fields of infectious diseases, epidemiology, public health, medicine, and blood banking, as well as consumers. The purpose of the committee is to advise the board about the safety of the blood supply, including existing and emerging pathogens. It should also assist the board in the process of risk assessment.”

Mr. Justice Horace Krever, Commission of Inquiry on the Blood System in Canada, Final report, Volume 3, p. 1055.

Advise the Board of Directors in a reasonable manner on matters concerning the safety of the blood supply, especially with regard to existing or emerging pathogens, and assist the Board in assessing risks:

  • Monitor and report to the Board on international developments to ensure the quality and safety of blood products (new tests, viral inactivation, donor selection, other methods).
  • Monitor, study and report to the Board on any emerging risk that could affect the quality and safety of blood products and the measures to be taken to eliminate or attenuate it, as the case may be.
  • Advise the Board on any other matter pertaining to reducing the risks associated with blood products.
  • Advise the Board on the scientific relevance of epidemiology research as well as its cost.
  • The committee is composed of 11 external voting members.
  • The committee shall meet at least once per year.
  • The Board of Directors shall appoint the external members after studying their curriculum vitæ.
  • The chair shall be held by an external member and voted by the members. The chair shall serve a term of two years and shall remain in that position until replaced or re-elected.
  • Members shall sit for a renewable term of five years. They shall remain in their position until they are replaced or their mandate is renewed.
  • At least two (2) members of the Héma-Québec Board of Directors shall sit as observers, but all members of the Héma-Québec Board shall be invited to attend meetings as observers, should they so wish.
  • Some Héma-Québec employees are invited to attend meetings and to perform clerical duties for the committee.
  • A donor representative shall be appointed by the Association of Blood Donation Volunteers.
  • A member of the Liaison Committee shall be appointed by that committee to sit on the Safety Advisory Committee. This member shall serve a term of five years.
  • At the request of Héma-Québec, a representative of the Canadian Blood Services (CBS) shall be appointed by the CBS. This member shall serve for a term of five years and shall remain in that position until replaced or re-appointed. In the event that this member terminates their employment with the CBS, their mandate shall end immediately and the CBS shall appoint another representative.

The member selection process must take into account the following fields:

Fields
Public health
Infectious diseases
Epidemiology
Transfusion medicine and practice
Recipient
Donor
Representative of the public
Representative of the Canadian Blood Services